Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway

Oleanolic acid (OA) and Lupeol (LU) belong to the class of natural triterpenes and are endowed with a wide range of biological activities, including cytotoxicity toward several cancer cell lines. In this context, we investigated a set of compounds obtained from the two natural precursors for the cytotoxicity against leukemia HL60 cells and the multidrug-resistant (MDR) variant HL60R. Six new semi-synthetic triterpenes have been synthetized, fully characterized, and were investigated together with other triterpenes compounds for their pharmacological mechanism of action. The interaction of the more cytotoxic compounds with the nuclear factor kappa B (NF-kappa B) pathway has been also evaluated with the aid of docking. The lupane-like compounds were more active than the precursor, while the oleane-like compounds showed more complex behavior. Both OA and LU derivatives possess a similar interaction pattern with the p65 subunit of NF-kappa B, justifying the similar trend in their ability to inhibit the binding of p65 to DNA. Further, some of the derivatives tested were able to increase I kappa B-alpha levels preventing the translocation of NF-kappa B to the nucleus. In conclusion, this study offers a deeper insight on the pharmacological action of triterpenes toward leukemia cells, and it improves the background useful for the development of new anti-cancer drugs.

Automated summary

This study investigates the cytotoxicity of natural triterpenes oleanolic acid (OA) and lupeol (LU) on leukemia cells. Six new semi-synthetic triterpenes were synthesized and characterized, and their pharmacological mechanism of action was studied. The lupane-like compounds showed higher activity than the precursor, while the oleane-like compounds had more complex behavior. Furthermore, the study found that these compounds interacted with the nuclear factor kappa B (NF-kappa B) pathway, possibly inhibiting NF-kappa B activity to exert anti-cancer effects.